Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China
Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China
RELEASE DATE
22-Jul-2005
22-Jul-2005
REGION
Europe
Europe
Research Code: B600-01-00-00-00
SKU: HC01104-EU-MR_05163
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01104-EU-MR_05163
Description
The objective of this research service is to provide detailed analysis of Pharmaceutical R&D outsourcing to India and China.
Table of Contents
Executive Summary
- Summary of Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China
Key Definitions
- Key Definitions
Abbreviations
- Abbreviations
R&D Outsourcing to India
Market Engineering Research
- Indian Industry Landscape
- Clinical Trials in India - Regulations
- SWOT Analysis
- Key Trends
CRO Profiles
- Key Market Engineering Measurements
- Outsourced Clinical Research Market Forecasts
Pharmaceutical Company Profiles
- Contract Research Organisations
R&D Outsourcing to China
CRO Profiles
Pharmaceutical Company Profiles
Strategic Anticipation
Potential Threats
Opportunities Clinical Research to India and China
Frost & Sullivan Awards
Pharmaceutical R&D Expenditure
Decision Support Database - India and China
Related Research
Popular Topics
The objective of this research service is to provide detailed analysis of Pharmaceutical R&D outsourcing to India and China.
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | B600-01-00-00-00 |
Is Prebook | No |